重组
RabMAb

Anti-beta III Tubulin抗体[EPR1568Y] (ab68193)

发表研究结果有使用 ab68193?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab68193 被引用在 5 文献中.

  • Chen D  et al. Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway. Cell Death Dis 9:123 (2018). PubMed: 29374144
  • Qiao LN  et al. Effect of electroacupuncture on thermal pain threshold and expression of calcitonin-gene related peptide, substance P and ?-aminobutyric acid in the cervical dorsal root ganglion of rats with incisional neck pain. Acupunct Med 35:276-283 (2017). PubMed: 28600329
  • Lebok P  et al. High levels of class III ß-tubulin expression are associated with aggressive tumor features in breast cancer. Oncol Lett 11:1987-1994 (2016). IHC . PubMed: 26998111
  • Kanmert D  et al. C-Terminally Truncated Forms of Tau, But Not Full-Length Tau or Its C-Terminal Fragments, Are Released from Neurons Independently of Cell Death. J Neurosci 35:10851-65 (2015). PubMed: 26224867
  • Listwak SJ  et al. Minimal NF-?B activity in neurons. Neuroscience 250:282-99 (2013). PubMed: 23872390

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

注册